Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 1999

View Archived Issues

CLASS study evaluates clomethiazole in acute stroke patients

Teijin in-licenses novel asthma therapeutic from Byk Gulden

SmithKline Beecham describes novel compounds for depression and other CNS disorders

Eradication of H. pylori has dubious therapeutic effect in patients with nonulcer dyspepsia

Selective dopamine D3 receptor modulators synthesized at SB

Takeda develops compounds that induce and/or enhance cell differentiation

Research at Jouveinal leads to potent and selective PDE4 inhibitors

More PDE5 inhibitors in the Pfizer pipeline

Novel antidiabetic agents in development at Novo Nordisk

CPMP approves angiotensin II antagonist for management of hypertension

Cortex licenses Ampakine rights to Organon

Orphan drug for iron overload offered for licensing by Biomedical Frontiers

FDA approves Pletal for intermittent claudication

Warner-Lambert updates U.S. status of Rezulin

MIST study provides further evidency of zanamivir's efficacy and safety

Epitope-based HIV vaccines show promise according to results from studies in primates

Novartis initiates phase III trial of schizophrenia treatment

XTL's first fully human MAb heading for clinical trials this quarter

Greater antitumor efficacy and less toxicity obtained with liposomal cisplatin

Beraprost to enter clinical trials in North America

Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham

Biogen: Q4 and FY 1998 highlights

Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Antitumor candidate originating in Kazakstan slated for development in U.S. and other countries

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...